Defining treatment‐resistant depression

Gaynes, Bradley N., Lux, Linda, Gartlehner, Gerald, Asher, Gary, Forman‐Hoffman, Valerie, Green, Josh, Boland, Erin, Weber, Rachel P. +5 more·2020·Depression and Anxiety
DOI 10.1002/da.22968

Cited by (446)

Items 301–400 of 446

  1. Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index
    Benjamin Wade, Ryan Pindale, Joan Albert Camprodon, James Luccarelli, Shuang Li, Robert C. Meisner, Stephen J. Seiner, Michael Henry · 2023 · Research Square
  2. Inibidores da monoaminoxidase e cetamina intravenosa: uma associação segura?
    Juliana Machado Leal dos Santos, Hugo Leonardo de Oliveira Couto, Dennison Carreiro Monteiro · 2022 · Debates em Psiquiatria
  3. Evolution of Depressive Symptoms Among Depression Subtypes of Clinical and Functional Variables in Primary Care in Chile
    Veronica G. Vitriol, Alfredo Cancino, Catalina Bustamante, María de la Luz Aylwin · 2024 · Journal of Primary Care & Community Health
  4. Sociodemographic predictors of the association between self-reported sleep duration and depression
    Mitha Al Balushi, Amar Sabri Ahmad, Sara Al Balushi, Sayed Javaid, Fatma Al‐Maskari, Abdishakur M Abdulle, Raghib Ali · 2024 · PLOS Global Public Health
  5. Which PTSD symptom would mediate the relationship between trauma exposure and depressive symptoms? Preliminary findings from two samples of trauma-exposed middle school students
    Hong Wang Fung, Guangzhe Frank Yuan, Caimeng Liu, Jiaxin Liu, Wei Shi, Stanley Kam Ki Lam · 2024 · Psychiatry Research Communications
  6. Use of intranasal esketamine in the treatment of treatment-resistant depression: A case report
    Stefan Jerotić, Joko Poleksić, Maja Ivković, Milan B. Latas · 2024 · Srpski medicinski casopis Lekarske komore
  7. Transdermal Scopolamine for Treatment-Resistant Major Depressive Disorder
    Mitchell B. Liester, Delia S Shash · 2024 · Cureus
  8. Esketamine treatment: advances in personalized clinical monitoring
    Ingrid Tonhajzerová, Zuzana Višňovcová, Nikola Ferencová, Veronika Kovacova, Ivan Farský, Igor Ondrejka · 2025 · Bratislavské lekárske listy/Bratislava medical journal
  9. Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodes
    Julia Myerson, Katrina A. Rufino, Sanjay J. Mathew, Marie Fletcher, Neil Puri, Hyuntaek Oh · 2025 · Journal of Affective Disorders
  10. Inhaled gases for treatment-resistant major depression
    Charles R. Conway, Brian J. Mickey, Ben Julian A. Palanca, Scott C. Tadler, Peter Nägele · 2022 · Elsevier eBooks
  11. Prediction of treatment-resistant depression using the 23andMe survey data
    Srinivasan Vairavan, Chao Tian, David A. Hinds, Vaibhav A. Narayan, Qingqin S. Li · 2025 · Scientific Reports
  12. Reward circuit function and treatment outcome following vALIC deep brain stimulation in treatment-resistant depression
    Nora Runia, Laurens A. van de Mortel, C. L. C. Smith, Isidoor O. Bergfeld, Bart P. de Kwaasteniet, Judy Luigjes, J. van Laarhoven, Peter Notten, Guus N. Beute, Pepijn van den Munckhof et al. · 2025 · Molecular Psychiatry
  13. Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions
    Morgan B. Talbot, Jessica M. Lipschitz, Omar Costilla-Reyes · 2025 · Journal of Affective Disorders
  14. Neurobiological mechanisms and recent advances in drug-based therapeutics in depression
    Hananeh Ahmadnia, Reza Abdollahzadeh, Hooman Hatami, Sara Masoumi, Seyed Mohammad Iman Moezzi, Kasra Shahsavari, Mahnaz Khanavi, Omid Yazarlu, Mohammad Tohidy Majd, Maede Hasanpour · 2025 · Neuroscience
  15. Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorder
    Brady D. Greene, Adam Fijtman, Nefize Yalın, Mark D. Kvarta, Philip R. Wang, Mani Yavi, Dede K. Greenstein, Carlos A. Zarate · 2025 · Journal of Affective Disorders
  16. Impact of difficult-to-treat depression for patients and society: a real-world study
    Sergio Benavente, Alba Parra, Jorge López‐Castromán, Ismaël Conejero, Pablo Alonso-Torres, Tatiana Caraballo López, Pablo Carrasco Arteaga, Enrique Baca‐García · 2025 · Frontiers in Psychiatry
  17. Has Deep Brain Stimulation Shown Its Full Potential in Treatment-Resistant Depression? A Scoping Review
    Puke Liene, Joëlle Rosselet Amoussou, Armin von Gunten, Julien Elowe · 2025 · Biological Psychiatry Global Open Science
  18. Comparison of rTMS and esketamine for treatment-resistant depression: A target trial emulation
    J. F. Chen, Chih-Wei Hsu, Yi-Ting Chen, Yi-Ya Fang, Ping‐Tao Tseng, Mu-Hong Chen, Kao Yu-Chen, Hsu Tien-Wei, Chih-Sung Liang · 2026 · Journal of Affective Disorders
  19. Treatment-Resistant Neuropsychiatric Symptoms in Dementia: Development of a Conceptual Framework
    Kevin O'Hara‐Veintimilla, Miguel Germán Borda, Javier Olivera, Manuel Sánchez-Pérez, Audun Osland Vik‐Mo, David Hui · 2026 · Journal of the American Medical Directors Association
  20. Treatment-resistant depression: time to rethink current definitions and clinical practice
    Walter Paganin · 2026 · Frontiers in Psychiatry
  21. The effect of non-invasive transcranial focused ultrasound for depression on the default mode network: an open-label pilot trial
    Jessica N. Schachtner, Jacob Francis Dahill-Fuchel, Diheng Zhang, Katja Ehrmann, Christopher R. Bawiec, Peter J. Hollender, Sarah B. Ornellas, Soren D. Konecky, Achal Singh Achrol, J. J. B. Allen · 2026 · Frontiers in Psychiatry
  22. Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational study
    Jan Sarlon, Deanne Thomi, Annette Beatrix Brühl, Timur Liwinski, Undine Emmi Lang · 2026 · Journal of Affective Disorders
  23. Moderators of treatment response in late-life depression
    David C. Steffens, Breno S Diniz, Neha Jain, Jessica Kluewer-DAmico, Kevin J. Manning, Lihong Wang · 2026 · Neuropsychopharmacology
  24. Association between the Gut Microbiota and Depression in Asian Populations: A Systematic Review and Meta-Analysis
    Mai Ngoc Luu, Nhu Thi Hanh Vu, Duc Trong Quach · 2026 · Digestive Diseases
  25. Sertraline blood concentrations and clinical efficacy in depression: a retrospective, exploratory determination of optimal therapeutic range
    Begoña Tapia-Alzuguren, Covadonga Canga-Espina, Patricio Molero, A. Aldaz · 2026 · Psychiatry Research
  26. Associations of CYP2B6, CYP2C19, and CYP2D6 isoforms and phenoconversion with sertraline pharmacokinetics
    Begoña Tapia-Alzuguren, Covadonga Canga-Espina, Patricio Molero, Azucena Aldaz · 2026 · PLoS ONE
  27. Connectomic Determinants of Subcallosal Cingulate Deep Brain Stimulation for Depression
    Ha Neul Song, Ki Sueng Choi, Brian Harris Kopell, Martijn Figee, Jip de Bruin, Jungho Cha, Patricio Riva‐Posse, Alexandre Boutet, Gavin J.B. Elias, Jürgen Germann et al. · 2026 · American Journal of Psychiatry
  28. Allostatic load as a predictor of response to repetitive transcranial magnetic stimulation in treatment resistant depression: Research protocol and hypotheses
    Christophe Longpré-Poirier, Robert‐Paul Juster, Jean‐Philippe Miron, Philippe Kerr, Enzo Cipriani, Véronique Desbeaumes Jodoin, Paul Lespérance · 2022 · Comprehensive Psychoneuroendocrinology
  29. Cervical muscle stiffness and parasympathetic nervous system improvements for treatment-resistant depression
    Takayoshi Matsui, Kazuhiro Hara, Makoto Iwata, Shuntaro Hojo, Nobuyuki Shitara, Yuzo Endo, Hideoki Fukuoka, Masaki Matsui, Hiroshi Kawaguchi · 2022 · BMC Musculoskeletal Disorders
  30. Treatment Resistant Depression: A Clinical Conundrum.
    Lind Grant-Oyeye · 2022 · PubMed Central
  31. A patient with multiple sclerosis and depression treated with repetitive transcranial magnetic stimulation (rTMS): A case report and review of literature
    Elif Cindik-Herbrüggen, Melike Duymaz · 2023 · Psychiatry Research Case Reports
  32. Cognitive Behavioral Therapy for Depression
    Maren Nyer, Lauren B. Fisher, Michael A. Pittman, John Matthews, Amy H. Farabaugh · 2023 · Current clinical psychiatry
  33. Simulation of nanocarrier-based targeted delivery of an antidepressant for major depressive disorder
    Vaibhav Mehra, Niloy Sarkar, Bibhu Biswal, Mahima Kaushik · 2023 · Molecular Simulation
  34. Monoamine oxidase inhibitors and tricyclic antidepressants for MDD
    Christie E Costello · 2023 · Current Psychiatry
  35. Design Optimization and Pharmacokinetic Study of Eletriptan Hydrobromide Loaded Solid Lipid Nanoparticle Nasal Gel Targeted to Brain
    Salma Sultana, A. Seetha Devi · 2024 · Research Journal of Pharmacy and Technology
  36. Psilocybin, moralization and psychotherapy: a scoping review and a case report
    Emiliano Loria, Elisabetta Lalumera, Ambra D’Imperio · 2024 · Philosophical Psychology
  37. Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada
    K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden Gregory O’Neill · 2024 · PLoS ONE
  38. Effects of Concomitant Use of Various Psychotropic Medications on the Treatment Response to Transcranial Magnetic Stimulation for Depression: A Literature Review
    Jordan Intrator, Jack Noto, Renzmark D Vallesteros, Morgan Peltier, John P. O’Reardon, Muhammad Abbas · 2024 · Cureus
  39. Eficácia e segurança da cetamina para o tratamento de depressão unipolar refratária: uma overview de revisões sistemáticas
    Gabriela Ribeiro PENA, Fernando Henrique Teixeira Zonzini, Aline de Fátima Bonetti · 2024 · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
  40. Therapeutic Approaches to Tackle the Challenge of Depression That Is Resistant to Treatment–A Narrative Review
    Md. Rajdoula Rafe, Abdul Waris, Pranoy Saha · 2025 · Health Science Reports
  41. Alterations in temporal-spatial brain entropy in treatment-resistant depression treated with nitrous oxide: Evidence from resting-state EEG
    Weizhuang Kong, Zhe Sun, Jing Zhu, Lingjiang Li, Guanru Wang, Xuexiao Shao, Xiaowei Li, Bin Hu · 2025 · Clinical Neurophysiology
  42. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
    Noah Chisamore, Erica S. Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre et al. · 2025 · The Canadian Journal of Psychiatry
  43. P.303 Augmenting strategies for treatment-resistant major depression using atypical antipsychotics
    I.A. Alexandru, I.E. Ghenoiu, Raluca Manolache, R.A. Lecu, M.I. Gionea · 2021 · European Neuropsychopharmacology
  44. Peripheral prognostic biomarkers of response in treatment-resistant depression
    Agorastos Agorastos, Theano Gkesoglou, Anastasios Kleidonopoulos, Vasilios P. Bozikas · 2021 · Psychiatriki
  45. Should residents be taught how to prescribe monoamine oxidase inhibitors?
    Samuel Reinfeld · 2022 · Current Psychiatry
  46. Current use of deep brain stimulation for treatment-resistant depression in different geographic regions of the world
    Jiating Xu · 2022 · International Journal of Frontiers in Medicine
  47. The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders
    Laura B. Teal, Shalonda Ingram, Michael Bubser, Elliot W. McClure, Carrie K. Jones · 2023 · Advances in neurobiology
  48. Loganin exerts antidepressant-like effects via Sigma-1R- and BDNF-dependent mechanisms
    Cong‐Yuan Xia, Yuming Wang, Man‐Ni Wang, Yuxuan Guo, Wenwen Lian, Yan Yu, Bing-Zhi Ma, Jie‐Kun Xu, Jun He, Weiku Zhang · 2023
  49. Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
    Parezanović, Marina, Stojiljković, Maja, Anđelković, Marina, Stevanović, Nina, Spasovski, Vesna, Ugrin, Milena, Komazec, Jovana, Tošić, Nataša, Pavlović, Sonja, Celic, Dejan et al. · 2023 · European Journal of Human Genetics
  50. A Novel Approach for Depression Detection through Extracted Skeletal Data during Scale Assessment
    Kaihong Zhang, Yumei Wan, Chuanbin Ning, Yunli Fan, Huajie Wang, Libo Xing, Wentao Li, Qi Tian, Yunshao Zheng · 2024 · Research Square
  51. Reply to: Toward Enhanced Methodological Rigor: Addressing Limitations in the Comparative Analysis of Probiotics and Antidepressants for Major Depressive Disorder Management
    Shilin Zhao, Jun Tao, Suisha Liang, Hein Min Tun · 2024 · Nutrition Reviews
  52. EPIDEMIOLOGY OF AEROMONAS HYDROPHILA STOOL ISOLATES IN A PEDIATRIC POPULATION
    Robert J. Leggiadro, Katarina Szabo · 1986 · The Pediatric Infectious Disease Journal
  53. The VTA-BLA-NAc circuit for sex reward inhibited by VTA GABAergic neurons under stress in male mice
    Linshan Sun, Jingjing You, Minghu Cui, Fengjiao Sun, Jiangong Wang, Wentao Wang, Dan Wang, Dunjiang Liu, Zhicheng Xu, Changyun Qiu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Evaluatıon of clınıcal varıables, treatment resıstance and factors affectıng the hospıtal stay duratıon ın gerıatrıc depressıve dısorders
    Selçuk Özdin · 2020 · Journal of Clinical Psychiatry
  55. El mundo en bandeja
    Jordi Doce · 2012 · Cuadernos hispanoamericanos
  56. Treatment-resistant depression: therapeutic options when first-line treatments fail
    Chloe Wigg, Sara Costi · 2021 · BJPsych Advances
  57. Peripheral biomarkers in Repeated Ketamine Infusions Trial
    Amanda Van Geel · 2021
  58. Participação da via P2X7-Inflamassoma NLRP3 no desenvolvimento das consequências comportamentais do estresse
    Aline Lulho Roncalho · 2022
  59. La investigación sobre el tratamiento de depresión con base en registros de historia clínica: análisis de una experiencia en un hospital universitario
    María Isabel Molina–Echeverry, Roger Figueroa-Paz, María Mercedes Cardozo-Rengifo, Valentina Galindo‐Velasco, Hernán G. Rincón-Hoyos · 2022 · Revista Colombiana de Psiquiatría
  60. Current state of knowledge concerning experimental applications for deep brain stimulation in specific neurologic and psychiatric disorders
    Michał Senger, Patrycja DORUCH, Kornelia Kędziora–Kornatowska · 2022 · Journal of Education Health and Sport
  61. Advances in the Treatment of Treatment-Resistant Depression
    日乐 格 · 2023 · Advances in Clinical Medicine
  62. Transcranial magnetic stimulation for treatment-resistant depression in patients with residual-organic insufficiency of the central nervous system
    S. R. Rangus, Boris Dmitrievich Tsygankov, А. O. Prosvetov, Yu. A. Yurshev · 2023 · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)
  63. Der Stellenwert der tiefen Hirnstimulation bei der schwer behandelbaren sowie therapierefraktären Depression
    Heide Baumann‐Vogel, Christian Ineichen, Lennart Henning Stieglitz, Wolfram Kawohl · 2023 · Praxis
  64. POSSIBLE EFFECTS OF THE ENDOCANNABINOID SYSTEM ON THE PATHOPHYSIOLOGY OF DEPRESSION: MEDICAL TREATMENT APPROACHES BASED ON THIS SYSTEM
    Ravza Nazlı Müyesseroğlu, Oğuzhan Yıldız · 2023 · TURKISH MEDICAL STUDENT JOURNAL
  65. Vagal nerve stimulation for treatment resistant depression: A report of two cases with a very long-term follow-up
    Nicolò Castelli, Vittoria Maria Luisa Cojazzi, Vittoria Nazzi, Michele Rizzi · 2023 · Journal of Affective Disorders Reports
  66. Propiedades psicométricas del Índice de Bienestar General en mujeres gestantes colombianas
    Yeison David Gallo-Barrera, Laura Vanessa Fuentes Vanegas, Ediltrudis Ramos de la Cruz · 2023 · Avances en Enfermería
  67. Terapia con estimulación magnética transcraneal repetitiva en trastorno depresivo mayor refractario: eficacia y seguridad. Revisión sistemática
    Juliana Ester Martín-López, Lorena Aguilera-Cobos, Maria Piedad Rosario-Lozano, Juan Antonio Blasco‐Amaro · 2023
  68. Therapeutic Strategies in Treatment-Resistant Depression: Myths and Evidence
    María Carmen Arenas · 2023 · Juniper Online Journal of Public Health
  69. Economic Evaluation of Mental Health Interventions
    Huajie Jin, Ali Jalali, Ben F. M. Wijnen, Yuhua Bao · 2023 · Frontiers research topics
  70. Ketamine for Traumatic Assault-Induced Depression: A Case Report
    Caitlyn B. Coffelt, Kyle Gibson, Jason VanLandingham · 2023 · Journal of Trauma Nursing
  71. Utilização de cetaminas em pacientes refratários ao tratamento convencional do TDM
    Matheus de Oliveira Furtado, Renan Chaparro Rodrigues Alves Barbosa Coelho · 2023 · Research Society and Development
  72. Association between Levels of Cortical Excitation/Inhibition and Clinical Response to Theta Burst Stimulation in Individuals with Major Depressive Disorder
    Nasim Kiaee · 2023
  73. Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
    Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś · 2023 · Journal of Education Health and Sport
  74. Incidence of treatment-resistant depression during the first mood depressive episode.
    Maroua Said, R. Hosni, Hend Jemli, Yosra Zgueb, Uta Ouali, H. Zalila, Fethi Nacef, Rabaa Jomli · 2023 · PubMed Central
  75. Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
    Erhan Kavakbasi, Helen Bauermeister, Lars Lemcke, Bernhard T. Baune · 2024 · Brain Sciences
  76. Exploring inner depths
    Joost J. Breeksema · 2024
  77. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I
    Samuele Cortese, Frank Besag, Bruce Clark, Chris P. Hollis, Joseph Kilgariff, Carmen Moreno, Dasha Nicholls, Paul Oliver Wilkinson, Marc Woodbury‐Smith, Aditya Sharma · 2024 · Journal of Psychopharmacology
  78. The use of inhaled gases in psychiatry
    Vasilis C. Hristidis, Peter Nägele, Ben Julian A. Palanca, Scott C. Tadler, Brian J. Mickey, Britt M. Gott, Charles R. Conway · 2024 · Elsevier eBooks
  79. Natural Substances in the Adjuvant Therapy of Depression
    Khara Lucius · 2024 · Integrative and Complementary Therapies
  80. Depressive Disorders
    Amanda C. Mihalik-Wenger, Uma Suryadevara, Justin Wenger, Meena Nuthi, Rita Hitching, Howard H. Fenn · 2024 · Springer eBooks
  81. Dépression résistante aux traitements chez les personnes âgées
    Philippe Thomas, C. Hazif-Thomas · 2024 · NPG. Neurologie, psychiatrie, gériatrie/NPG
  82. Modafinil Use in an Adolescent With Major Depressive Disorder.
    Ecem Özer Çakır, O. Karakuş, Ibrahim Adak · 2024 · Journal of Clinical Psychopharmacology
  83. Biomarkers from bench to bedside
    Helena Voetterl · 2024
  84. Computational Phenotyping of Treatment-Resistant Depression prior to Electroconvulsive Therapy
    Rachel E. Jones, L. Paul Sands, Jonathan D. Trattner, Angela Jiang, Christina K. Johnson, Evelyn B. Farkas, Predrag V. Gligorovic, Heather E. Douglas, Rommel Ramos, Kenneth T. Kishida · 2024 · medRxiv
  85. Other Biological Treatments Used in Depression
    Bahar Demir, Süleyman Dönmezdil · 2024
  86. Comorbidity, Treatment, and Service Utilization Patterns in Difficult-to-Treat Depression Patients: A Retrospective Study in a Portuguese Community Mental Health Team
    João Gouveia, Marta R. Neves, Nuno Gonçalo Gomes Fernandes Madeira, Vítor Santos, António Macedo · 2024 · Medicina
  87. Using Prefrontal EEG-Derived Theta Cordance to Predict the Response to Anodal Transcranial Direct Current Stimulation (atDCS) in Female Patients with Treatment-Resistant Depression
    Seyed Ruhollah Hosseini, Roghieh Nooripour, Nikzad Ghanbari · 2024 · Research Square
  88. A Comprehensive Approach to Treatment-Resistant Depression: Addressing Gender Disparities, Psychotherapy Integration, and Emerging Avenues
    Aysesu Bozdogan · 2024 · PsyPag Quarterly
  89. Methylphenidate augmentation for electroconvulsive therapy-resistant major depressive disorder
    Varshitha Tholasappa, Naveen Achyuta Yedavally, Bijoylaxmi Lairenlakpam, Lakhan Motwani, Radha Dangaich, Shyam Sundar Arumugham · 2025 · Asian Journal of Psychiatry
  90. Characteristics of patients with major depressive disorder eligible for and prescribed esketamine, treatment outcomes and physician experiences: a physician and patient survey in the United States
    Manish K. Jha, Amanda Teeple, Jason Shepherd, Alexander Gillespie, Nikisha Grant, Ashley Mortimer, Sophie Kirkman, Chloe Middleton‐Dalby, Kruti Joshi · 2025 · Current Medical Research and Opinion
  91. Differential Impact of Extracts from Distinct Sceletium Tortuosum Ecotypes on Central Neurotransmitter Concentrations in C57bl/6 Mice
    Catherine H. Kaschula, Anna‐Mart Engelbrecht, Nokwanda Pearl Makunga, Magriet Muller, André J. de Villiers, Kamano Angela Mochoele, Sarel Jacobus Brand, Jo-Anne Stroebel, Willem A. L. van Otterlo, De Wet Wolmarans · 2025 · SSRN Electronic Journal
  92. Antidepressant resistance and risks of prior atopic and autoimmune diseases among adolescents and young adults with major depressive disorder
    Fan-Hsuan Kung, Chih‐Ming Cheng, Shih‐Jen Tsai, Tung‐Ping Su, Tzeng-Ji Chen, Ya‐Mei Bai, Mu‐Hong Chen, Tien‐Wei Hsu, Chih‐Sung Liang · 2025 · Journal of Affective Disorders
  93. Transcranial direct current simulation as an adjunctive treatment for treatment-resistant depression in hospitalized patients: A feasibility study protocol
    John Wing Li, Caili Ren, Vanessa Pazdernik, Simon Kung, Michael R. Basso, Paul E. Croarkin, Bina Aaron, Amanda M. Anderson, Courtney Caves, Misty N. Hemm et al. · 2025 · PLoS ONE
  94. Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT1A Receptor for Therapeutic Potential in Depression
    Shu-jie Li, Qingning Yuan, Wen‐Yuan Wu, Ao Tan, Zhihan Chen, Duo Chen, Hong Shan, Qin-yu Chu, Wen Hu, Kai Wu et al. · 2025 · SSRN Electronic Journal
  95. Unexpected Anti-depressant Effects Seen with Full Body Pulsed Electromagnetic Treatment when Given for Chronic Back Pain in a Patient with Co-existent Severe Treatment Resistant Depression: A Case Report
    Nishita Sharma, Jyotsna Punj · 2025 · International Journal of convergence in healthcare
  96. Therapeutic Ketamine in Youth with Major Depression Versus Illicit Use: Initial Clinical Findings with Short-Term Benefits and Long-Term Unknowns
    Małgorzata Zaremba, Patrycja Kleczkowska · 2025 · Neuromethods
  97. Comparing the effectiveness of agomelatine, bupropion, and sertraline in the treatment of non-psychotic major depressive disorder: a double- blind, randomized clinical trial
    Romina Hamzehpour, Ashraf Ahangar, Elham Motevalli Alamouti, Farzan Khierkhah, Mahboobeh Khoozan, Hoda Shirafkan · 2025 · Psiquiatría Biológica
  98. Characterising the depression pathway in secondary care: a UK-based epidemiological study of patient characteristics, comorbidities, and treatments
    Laura A. Hannah, Laura Angco, Emanuele Felice Osimo, Jonathan R. Lewis, Cathy M. Walsh, Rudolf N. Cardinal · 2025 · medRxiv
  99. Longitudinal associations between psychological factors, community integration, and suicide risks among patients with treatment-resistant depression in Vietnam
    Phạm Thị Thu Hương, Chia‐Yi Wu, Ming‐Been Lee, Nguyen Van Tuan, Pham Thi Thu Hien, Nguyễn Thị Lan Anh, Nguyen Thi Son, Nguyen Thi Thu Hien · 2025 · Frontiers in Psychiatry
  100. Exploring the neurotherapeutic potential of Strychnos potatorum Linn: A network pharmacology approach to neuropsychiatric disorders
    Vandana Kumari, Shalini Rai, Shivani Ghildiyal, Abha Vashistha, Heena Saini · 2025 · Pharmacological Research - Natural Products